Application of Deep Learning for Diagnosing, Classifying, and Treating Age-Related Macular Degeneration

被引:11
|
作者
Gong, Dan [1 ]
Kras, Ashley [2 ]
Miller, John B. [1 ,2 ]
机构
[1] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Retina Serv, Boston, MA 02115 USA
[2] Massachusetts Eye & Ear Infirm, Harvard Retinal Imaging Lab, Boston, MA 02114 USA
关键词
Artificial intelligence; deep learning; age-related macular degeneration;
D O I
10.1080/08820538.2021.1889617
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Age-related macular degeneration (AMD) affects nearly 200 million people and is the third leading cause of irreversible vision loss worldwide. Deep learning, a branch of artificial intelligence that can learn image recognition based on pre-existing datasets, creates an opportunity for more accurate and efficient diagnosis, classification, and treatment of AMD on both individual and population levels. Current algorithms based on fundus photography and optical coherence tomography imaging have already achieved diagnostic accuracy levels comparable to human graders. This accuracy can be further increased when deep learning algorithms are simultaneously applied to multiple diagnostic imaging modalities. Combined with advances in telemedicine and imaging technology, deep learning can enable large populations of patients to be screened than would otherwise be possible and allow ophthalmologists to focus on seeing those patients who are in need of treatment, thus reducing the number of patients with significant visual impairment from AMD.
引用
收藏
页码:198 / 204
页数:7
相关论文
共 50 条
  • [31] Fundus Image Deep Learning Study to Explore the Association of Retinal Morphology with Age-Related Macular Degeneration Polygenic Risk Score
    Sendecki, Adam
    Ledwon, Daniel
    Tuszy, Aleksandra
    Nycz, Julia
    Wasowska, Anna
    Boguszewska-Chachulska, Anna
    Mitas, Andrzej W.
    Wylegala, Edward
    Teper, Slawomir
    BIOMEDICINES, 2024, 12 (09)
  • [32] Imaging and artificial intelligence for progression of age-related macular degeneration
    Romond, Kathleen
    Alam, Minhaj
    Kravets, Sasha
    de Sisternes, Luis
    Leng, Theodore
    Lim, Jennifer, I
    Rubin, Daniel
    Hallak, Joelle A.
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 246 (20) : 2159 - 2169
  • [33] LASERCOAGULATION OF AGE-RELATED MACULAR DEGENERATION
    ROIDER, J
    LAQUA, H
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1995, 206 (06) : 428 - 437
  • [34] Lipids an Age-related Macular Degeneration
    Kishan, Amar U.
    Modjtahedi, Bobeck S.
    Martins, Elisabeth N.
    Modjtahedi, Sara P.
    Morse, Lawrence S.
    SURVEY OF OPHTHALMOLOGY, 2011, 56 (03) : 195 - 213
  • [35] Pharmacotherapy of age-related macular degeneration
    Ahmadi, M. Amir
    Lim, Jennifer I.
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (17) : 3045 - 3052
  • [36] Prevention of age-related macular degeneration
    Wong I.Y.H.
    Koo S.C.Y.
    Chan C.W.N.
    International Ophthalmology, 2011, 31 (1) : 73 - 82
  • [37] Age-related macular degeneration and nutrition
    Lecerf, J. M.
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2017, 21 (1-2): : 12 - 17
  • [38] Lifestyle and age-related macular degeneration
    Wickremasinghe, Sanjeewa S.
    Chong, Elaine W. T.
    Guymer, Robyn H.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2009, 4 (01) : 79 - 102
  • [39] Genetics of age-related macular degeneration: application to drug design
    Chu, Xi K.
    Tuo, Jingsheng
    Chan, Chi-Chao
    FUTURE MEDICINAL CHEMISTRY, 2013, 5 (01) : 13 - 15
  • [40] Inflammation in Age-Related Macular Degeneration
    Ozaki, Ema
    Campbell, Matthew
    Kiang, Anna-Sophia
    Humphries, Marian
    Doyle, Sarah L.
    Humphries, Peter
    RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY, 2014, 801 : 229 - 235